요천추 방사통 시장 보고서(2026년)

Lumbosacral radicular pain is pain originating in the lower spine (lumbar and sacral regions) that radiates along a spinal nerve into the leg. It is commonly caused by nerve root compression or irritation, often resulting from conditions such as a herniated disc or spinal stenosis.

The main treatments for lumbosacral radicular pain include pharmacological therapies, non-pharmacological therapies, and interventional procedures. Pharmacological treatments involve the use of medications to diagnose, treat, or prevent medical conditions. Administration routes include oral, topical, injectable, and implantable methods. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, serving end users such as hospitals, specialty clinics, rehabilitation centers, and homecare settings.

Tariffs have raised costs in the lumbosacral radicular pain market by affecting imports of pain management drugs, injection devices, implantable stimulators, and rehabilitation equipment. Interventional procedures and pharmacological treatments are most impacted, particularly in North America and Europe due to reliance on imported medical devices and specialty drugs. Hospitals, rehabilitation centers, and specialty clinics face higher operational expenses. Positively, tariffs are supporting local manufacturing of pain management devices and injectable pharmaceuticals.

The lumbosacral radicular pain market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain market statistics, including lumbosacral radicular pain industry global market size, regional shares, competitors with a lumbosacral radicular pain market share, detailed lumbosacral radicular pain market segments, market trends and opportunities, and any further data you may need to thrive in the lumbosacral radicular pain industry. This lumbosacral radicular pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lumbosacral radicular pain market size has grown strongly in recent years. It will grow from $0.97 billion in 2025 to $1.02 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to aging population, spinal degenerative disorders, opioid-based pain management, hospital pain clinics, orthopedic surgery volumes.

The lumbosacral radicular pain market size is expected to see strong growth in the next few years. It will grow to $1.28 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to non-opioid pain therapy adoption, outpatient pain procedures, digital pain monitoring tools, minimally invasive spine technologies, rehabilitation program expansion. Major trends in the forecast period include rising use of multimodal pain management, growth of interventional spine procedures, increased demand for non-opioid therapies, expansion of rehabilitation-based care, adoption of minimally invasive pain treatments.

The increasing prevalence of degenerative spinal conditions is expected to drive growth in the lumbosacral radicular pain market in the coming years. Degenerative spinal conditions are disorders caused by the gradual wear and tear of the spine over time. Their rise is attributed to aging populations and lifestyle factors that increase spinal stress and nerve compression, creating greater demand for diagnosis and treatment. Lumbosacral radicular pain signals nerve root irritation or compression, helping clinicians identify underlying degenerative spinal conditions and guide effective management. For example, in May 2023, according to the University of Sydney, an Australia-based public university, it is projected that more than 800 million people worldwide will experience back discomfort by 2050. Therefore, the growing prevalence of degenerative spinal conditions is driving the lumbosacral radicular pain market.

The rising prevalence of obesity is also expected to propel growth in the lumbosacral radicular pain market. Obesity is a medical condition defined by excessive body fat accumulation, typically a body mass index (BMI) of 30 or higher, which increases the risk of multiple health complications. The increase in obesity is driven by sedentary lifestyles and widespread consumption of high-calorie, nutrient-poor foods, as modern work environments often involve prolonged sitting and limited physical activity. Excess body weight places additional mechanical stress on the lumbar spine, contributing to nerve compression and inflammation, which increases the incidence of lower back and leg pain. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, up from 64.0% in 2022 to 2023. Therefore, the rising prevalence of obesity is driving the lumbosacral radicular pain market.

In October 2024, Stryker Corporation, a US-based medical technology company, acquired Vertos Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aims to strengthen its minimally invasive spine treatment portfolio by integrating Vertos Medical's innovative technologies, improving patient outcomes, and expanding its leadership in the spinal health market. Vertos Medical Inc. is a US-based company specializing in minimally invasive treatments for lumbar spinal stenosis (LSS).

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lumbosacral radicular pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lumbosacral radicular pain market includes revenues earned by entities by providing services such as non-surgical treatment services, interventional pain management services, and rehabilitation and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lumbosacral Radicular Pain Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lumbosacral radicular pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lumbosacral radicular pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lumbosacral radicular pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment Type: Pharmacological Treatment; Non-Pharmacological Treatment; Interventional Procedures
• 2) By Route Of Administration: Oral; Topical; Injectable; Implantable
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By End User: Hospitals; Specialty Clinics; Rehabilitation Centers; Homecare Settings
• Subsegments:
• 1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs; Opioids; Anticonvulsants; Antidepressants; Muscle Relaxants; Corticosteroids
• 2) By Non-Pharmacological Treatment: Physical Therapy; Exercise And Rehabilitation Programs; Chiropractic Care; Acupuncture; Cognitive Behavioral Therapy; Heat And Cold Therapy
• 3) By Interventional Procedures: Epidural Steroid Injections; Radiofrequency Ablation; Nerve Root Blocks; Spinal Cord Stimulation; Minimally Invasive Decompression; Intrathecal Drug Delivery Systems
• Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Nevro Corp.; SPR Therapeutics; Saluda Medical Pty Ltd.; Nalu Medical Inc.; Abbott Neuromodulation; Stryker Corporation; Zimmer Biomet Holdings Inc.; Globus Medical Inc.; NuVasive Inc.; Orthofix Medical Inc.; B. Braun Melsungen AG; Teleflex Incorporated; Merit Medical Systems Inc.; Avanos Medical Inc.; Halyard Health Inc.; Terumo Corporation; Baxter International Inc.; Fresenius Kabi AG; Hikma Pharmaceuticals PLC; Pfizer CentreOne; Teva Pharmaceutical Industries Ltd.; Mallinckrodt Pharmaceuticals; Sun Pharmaceutical Industries Ltd.; Lupin Limited; Zydus Lifesciences Ltd.; Cipla Ltd.; Dr. Reddy's Laboratories Ltd.; Amneal Pharmaceuticals Inc.; Perrigo Company plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Lumbosacral Radicular Pain Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Lumbosacral Radicular Pain Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Lumbosacral Radicular Pain Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Lumbosacral Radicular Pain Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Use Of Multimodal Pain Management
  • 4.2.2 Growth Of Interventional Spine Procedures
  • 4.2.3 Increased Demand For Non-Opioid Therapies
  • 4.2.4 Expansion Of Rehabilitation-Based Care
  • 4.2.5 Adoption Of Minimally Invasive Pain Treatments

5. Lumbosacral Radicular Pain Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Pain Clinics
• 5.3 Rehabilitation Centers
• 5.4 Orthopedic Clinics
• 5.5 Homecare Settings

6. Lumbosacral Radicular Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lumbosacral Radicular Pain Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Lumbosacral Radicular Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Lumbosacral Radicular Pain Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Lumbosacral Radicular Pain Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Lumbosacral Radicular Pain Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lumbosacral Radicular Pain Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lumbosacral Radicular Pain Market Segmentation

• 9.1. Global Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures
• 9.2. Global Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Topical, Injectable, Implantable
• 9.3. Global Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.4. Global Lumbosacral Radicular Pain Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings
• 9.5. Global Lumbosacral Radicular Pain Market, Sub-Segmentation Of Pharmacological Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids
• 9.6. Global Lumbosacral Radicular Pain Market, Sub-Segmentation Of Non-Pharmacological Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy
• 9.7. Global Lumbosacral Radicular Pain Market, Sub-Segmentation Of Interventional Procedures, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

10. Lumbosacral Radicular Pain Market Regional And Country Analysis

• 10.1. Global Lumbosacral Radicular Pain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Lumbosacral Radicular Pain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lumbosacral Radicular Pain Market

• 11.1. Asia-Pacific Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lumbosacral Radicular Pain Market

• 12.1. China Lumbosacral Radicular Pain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lumbosacral Radicular Pain Market

• 13.1. India Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lumbosacral Radicular Pain Market

• 14.1. Japan Lumbosacral Radicular Pain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lumbosacral Radicular Pain Market

• 15.1. Australia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lumbosacral Radicular Pain Market

• 16.1. Indonesia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lumbosacral Radicular Pain Market

• 17.1. South Korea Lumbosacral Radicular Pain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lumbosacral Radicular Pain Market

• 18.1. Taiwan Lumbosacral Radicular Pain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lumbosacral Radicular Pain Market

• 19.1. South East Asia Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lumbosacral Radicular Pain Market

• 20.1. Western Europe Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lumbosacral Radicular Pain Market

• 21.1. UK Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lumbosacral Radicular Pain Market

• 22.1. Germany Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lumbosacral Radicular Pain Market

• 23.1. France Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lumbosacral Radicular Pain Market

• 24.1. Italy Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lumbosacral Radicular Pain Market

• 25.1. Spain Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lumbosacral Radicular Pain Market

• 26.1. Eastern Europe Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lumbosacral Radicular Pain Market

• 27.1. Russia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lumbosacral Radicular Pain Market

• 28.1. North America Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lumbosacral Radicular Pain Market

• 29.1. USA Lumbosacral Radicular Pain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lumbosacral Radicular Pain Market

• 30.1. Canada Lumbosacral Radicular Pain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lumbosacral Radicular Pain Market

• 31.1. South America Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lumbosacral Radicular Pain Market

• 32.1. Brazil Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lumbosacral Radicular Pain Market

• 33.1. Middle East Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lumbosacral Radicular Pain Market

• 34.1. Africa Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lumbosacral Radicular Pain Market Regulatory and Investment Landscape

36. Lumbosacral Radicular Pain Market Competitive Landscape And Company Profiles

• 36.1. Lumbosacral Radicular Pain Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Lumbosacral Radicular Pain Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Lumbosacral Radicular Pain Market Company Profiles
  • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Nevro Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. SPR Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Saluda Medical Pty Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Lumbosacral Radicular Pain Market Other Major And Innovative Companies

• Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG

38. Global Lumbosacral Radicular Pain Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lumbosacral Radicular Pain Market

40. Lumbosacral Radicular Pain Market High Potential Countries, Segments and Strategies

• 40.1 Lumbosacral Radicular Pain Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Lumbosacral Radicular Pain Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Lumbosacral Radicular Pain Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer